Cohance Lifesciences Ltd vs Ngl Fine Chem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Cohance Lifesciences Ltd is ₹ 480.95 as of 06 May 15:30 . The P/E Ratio of Cohance Lifesciences Ltd changed from 34.8 on March 2021 to 110.3 on March 2025 . This represents a CAGR of 25.95% over 5 yearsThe P/E Ratio of NGL Fine Chem Ltd changed from 16.7 on March 2021 to 32.6 on March 2025 . This represents a CAGR of 14.31% over 5 years The Market Cap of Cohance Lifesciences Ltd changed from ₹ 12611 crore on March 2021 to ₹ 29524 crore on March 2025 . This represents a CAGR of 18.55% over 5 yearsThe Market Cap of NGL Fine Chem Ltd changed from ₹ 947.42 crore on March 2021 to ₹ 688.7 crore on March 2025 . This represents a CAGR of -6.18% over 5 years The revenue of Cohance Lifesciences Ltd for the Dec '25 is ₹ 550.71 crore as compare to the Sep '25 revenue of ₹ 571.17 crore. This represent the decline of -3.58% The revenue of NGL Fine Chem Ltd for the Dec '25 is ₹ 132.12 crore as compare to the Sep '25 revenue of ₹ 122.31 crore. This represent the growth of 8.02% The ebitda of Cohance Lifesciences Ltd for the Dec '25 is ₹ 96.65 crore as compare to the Sep '25 ebitda of ₹ 136.55 crore. This represent the decline of -29.22% The ebitda of NGL Fine Chem Ltd for the Dec '25 is ₹ 26.93 crore as compare to the Sep '25 ebitda of ₹ 19.21 crore. This represent the growth of 40.19% The net profit of Cohance Lifesciences Ltd changed from ₹ 75.37 crore to ₹ 29.02 crore over 7 quarters. This represents a CAGR of -42.04% The net profit of NGL Fine Chem Ltd changed from ₹ 9.22 crore to ₹ 15.69 crore over 7 quarters. This represents a CAGR of 35.50% The Dividend Payout of Cohance Lifesciences Ltd changed from 16.5 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of NGL Fine Chem Ltd changed from 1.95 % on March 2021 to 5.97 % on March 2025 . This represents a CAGR of 25.08% over 5 years .

About Cohance Lifesciences Ltd

Cohance Lifesciences Limited, formerly known as Suven Pharmaceuticals Limited was incorporated on November 6, 2018.
The name of the Company has been changed to Cohance Lifesciences Limited w.e.f.
May 7, 2025.
Cohance Lifesciences Ltd is an integrated Contract Development and Manufacturing Operations (CDMO) company that serves leading global life science and fine chemical majors.
The Company's comprehensive services encompass- Custom Synthesis, Process R&D, Scale-Up, and Contract Manufacturing of intermediates, APIs, and formulations. Company is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.

About NGL Fine Chem Ltd

NGL Fine-Chem Limited was incorporated on December 18, 1981 as a Private Limited Company in the State of Maharashtra.
The Company became a Public Limited Company.
The Company has got its registered office and factory at New Bombay.
It was promoted by Mr. A.G.Lawande, Mr.R. J. Nachane joined Mr.A.G.Lawande for actively participating in the Management of the Company in 1989.
The Company is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health.

FAQs for the comparison of Cohance Lifesciences Ltd and NGL Fine Chem Ltd

Which company has a larger market capitalization, Cohance Lifesciences Ltd or NGL Fine Chem Ltd?

Market cap of Cohance Lifesciences Ltd is 18,399 Cr while Market cap of NGL Fine Chem Ltd is 1,640 Cr

What are the key factors driving the stock performance of Cohance Lifesciences Ltd and NGL Fine Chem Ltd?

The stock performance of Cohance Lifesciences Ltd and NGL Fine Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Cohance Lifesciences Ltd and NGL Fine Chem Ltd?

As of May 6, 2026, the Cohance Lifesciences Ltd stock price is INR ₹480.95. On the other hand, NGL Fine Chem Ltd stock price is INR ₹2654.75.

How do dividend payouts of Cohance Lifesciences Ltd and NGL Fine Chem Ltd compare?

To compare the dividend payouts of Cohance Lifesciences Ltd and NGL Fine Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.